To investigate the role of JUN, CEBPB and HDAC3 in the drug resistance phenotype of hypoxic GBM, we detected the inhibitory effects of temozolomide (TMZ) in four different GBM cell lines, namely U87-MG, LN229, 090116, and 091214. Here, CEBPB is linked to glioblastoma.